Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,375 | -162,667 | -120,335 | -102,487 | -42,795 |
| Depreciation Amortization | -3,331 | 4,104 | 9,603 | 6,427 | 6,482 |
| Accounts receivable | 7,522 | -2,635 | -4,612 | 4,873 | -1,537 |
| Accounts payable and accrued liabilities | -4,977 | 3,207 | -4,417 | 910 | 3,642 |
| Other Working Capital | -18,376 | -20,712 | 4,208 | -3,700 | -17,940 |
| Other Operating Activity | 29,335 | 34,264 | 42,324 | 10,481 | 10,974 |
| Operating Cash Flow | $-132,202 | $-144,439 | $-73,229 | $-83,496 | $-41,174 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 115,539 | 16,180 | -69,966 | -49,119 | 52,212 |
| PPE Investments | -1,252 | -1,858 | -1,684 | -1,879 | -3,489 |
| Investing Cash Flow | $114,287 | $14,322 | $-71,650 | $-50,998 | $48,723 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,775 | 4,787 | 14,881 | 14,208 | 180,751 |
| Other Financing Activity | 0 | 49,446 | 134,776 | 21,330 | 0 |
| Financing Cash Flow | $1,775 | $54,233 | $149,657 | $35,538 | $180,751 |
| Beginning Cash Position | 77,410 | 153,294 | 148,516 | 247,472 | 59,172 |
| End Cash Position | 61,270 | 77,410 | 153,294 | 148,516 | 247,472 |
| Net Cash Flow | $-16,140 | $-75,884 | $4,778 | $-98,956 | $188,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -132,202 | -144,439 | -73,229 | -83,496 | -41,174 |
| Capital Expenditure | -1,252 | -1,858 | -1,684 | -1,879 | -3,489 |
| Free Cash Flow | -133,454 | -146,297 | -74,913 | -85,375 | -44,663 |